IDENTIFICATION AND REPORTING OF ADVERSE DRUG REACTIONS IN THE PHARMACOVIGILANCE CENTER OF A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i5.46973Keywords:
Adverse drug reactions, Causality assessment, Pharmacovigilance, Severity scale, Anti-microbial agents, Skin reactionsAbstract
Objective: In spite of being the most vital part of the health-care system, medicines can become the reason for hospitalization or prolonged hospital stay if not used with vigilance. Adverse drug reactions (ADRs) have become a major reason for the rise in morbidity and mortality rate. Hence, monitoring of the ADRs and understanding their route cause is utmost important in a clinical setup. This project aims to monitor the ADRs and improve ADR reporting in the hospital.
Methods: The work was carried out at a tertiary care hospital in Pune. Daily visit to different departments was done and patients were screened from admission to discharge during the study period. ADRs occurring due to chemotherapy, overdose, intoxication, drug abuse, accidental/intentional poisoning, and blood/blood products were excluded. The data of ADRs reported in the hospital in the past 3 years were collected and compared with the prospective data to analyze the improvement in ADR reporting in the hospital.
Results: ADRs occurring in males were more than those in females. Adults between the age group of 20 and 59 years were more prone to ADRs. Maximum number of ADRs reported were occurring due to antimicrobial agents. The organ that was commonly affected due to ADRs was skin.
Conclusion: High incidence of ADRs insists on vigilant monitoring to prevent its further recurrence. More studies need to be conducted to know the exact occurrence and prevalence of ADRs in the Indian population. Creating awareness among the HCPs for reporting suspected ADRs will help to improve patient safety. ADR reporting can be enhanced if the involvement of clinical pharmacists is strengthened in health-care centers.
Downloads
References
Lihite RJ, Lahkar M, Das S, Hazarika D, Kotni M, Maqbool M, et al. A study on adverse drug reactions in a tertiary care hospital of Northeast India. Alex J Med 2017;53:151-6. doi: 10.1016/j.ajme.2016.05.007
Mulchandani R, Kakkar AK. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions. Int J Risk Saf Med 2019;30:33-44. doi: 10.3233/JRS-180025, PMID 30175985
Fletcher AP. EU pharmacovigilance guidelines: Review. Adverse Drug React Toxicol Rev 2000;19:123-6. PMID 10967747
Wadhwa T, Gamal S, Sheikh E, Rao PG. Monitoring and reporting of adverse drug reactions due to cardiovascular drugs in patients admitted to a secondary Care Hospital in Northern Emirate-a prospective surveillance study. Indian J Pharm Pract 2018;11: pp 72.
Rajakannan T, Mallayasamy S, Guddattu V, Kamath A, Vilakkthala R, Rao PG, et al. Cost of adverse drug reactions in a south Indian tertiary care teaching hospital. J Clin Pharmacol 2012;52:559- 65. doi: 10.1177/0091270011398867, PMID 21505086
Rekha MM. A study on role of doctor of pharmacy in identification and reporting of adverse drug reactions in an antiretroviral therapy ward of a teritary care teaching hospital. PharmaTutor 2017;5:33-42.
Guidelines for Detecting and Reporting Adverse Drug Reactions. Individual Case Safety Reports for Healthcare Professionals. Jordan: Ration Drug Use Pharmacovigilance Department-JFDA; 2014.
Ramakrishnaiah H, Krishnaiah V, Pundarikaksha HP, Ramakrishna V. A prospective study on adverse drug reactions in outpatients and inpatients of medicine department in a tertiary care hospital. Int J Basic Clin Pharmacol 2015;4:515-21.
Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, et al. The economic burden of preventable adverse drug reactions: A systematic review of observational studies. Expert Opin Drug Saf 2018;17:681-95. doi: 10.1080/14740338.2018.1491547, PMID 29952667
Lee CY, Chen YP. Machine learning on adverse drug reactions for pharmacovigilance. Drug Discov Today 2019;24:1332-43. doi: 10.1016/j.drudis.2019.03.003, PMID 30876845
Cacabelos R, Cacabelos N, Carril JC. The role of pharmacogenomics in adverse drug reactions. Expert Rev Clin Pharmacol 2019;12:407-42. doi: 10.1080/17512433.2019.1597706, PMID 30916581
International drug monitoring: The role of national centres, report of a WHO meeting [Held in Geneva from 20 to 25 September 1971]. World Health Organization, 1972. Available from: https://apps. who.int/iris/handle/10665/40968
Watson S, Caster O, Rochon PA, den Ruijter H. Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalmedicine 2019;17:100188. doi: 10.1016/j.eclinm.2019.10.001, PMID 31891132
Patton K, Borshoff DC. Adverse drug reactions. Anaesthesia 2018;73Suppl 1:76-84. doi: 10.1111/anae.14143, PMID 29313907
Commission IP. Guidance Document for Spontaneous Adverse Drug Reaction Reporting. India: Pharmacovigilance Program India; 2014. p. 1.
Kalyani SS, Srihitha P. An epidemiological study on adverse drug reactions in Indian population: Meta-analysis. Int J Pharm Clin Res 2017;9:654-9.
Behera SK, Das S, Xavier AS, Velupula S, Sandhiya S. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm 2018;40:903-10. doi: 10.1007/s11096-018-0694-9, PMID 30051231
Shamna M, Dilip C, Ajmal M, Mohan PL, Shinu C, Jafer CP, et al. A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital. Saudi Pharm J 2014;22:303-8. doi: 10.1016/j. jsps.2013.06.004, PMID 25161373
James J, Rani J. A prospective study of adverse drug reactions in a tertiary Care Hospital in South India. Asian J Pharm Clin Res 2020;13:89-92.
Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol 2008;65:210-6. doi: 10.1111/j.1365-2125.2007.02993.x, PMID 17662089
Chandrashekar S, Fredy IC, Sandeep KR. Prevention and management of adverse drug reactions. Am J Pharmacol Sci 2016;2:1531-9.
Darji NH, Jadav S, Doshi C, Hedamba R, Mistry R, Trivedi H. An intensive monitoring of adverse drug reaction in indoor patients of medicine department at tertiary care teaching hospital. Int J Basic Clin Pharmacol 2016;5:742-7.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Vaishnavi Survase, Jasmin Shimpi, Tanvi Sasawade, Shubham Tripathi
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
